eXmoor Pharma News and Resources

CDMO News

eXmoor Pharma Secures MIA(IMP) License from MHRA

eXmoor Pharma has reached a key milestone by obtaining a Manufacturing and Import Authorization for Investigational Medicinal Products (MIA(IMP)) license from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA). This authorization permits the company to produce good manufacturing practice

Read More »
Who do you rate?
Recommend a Supplier

Help us find the most innovative and trusted suppliers in Pharma and Biotech.